Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prothena Corporation PLC (NASDAQ:PRTA)

57.95
Delayed Data
As of 4:00pm ET
 +0.04 / +0.07%
Today’s Change
40.58
Today|||52-Week Range
70.00
+17.81%
Year-to-Date
No recent news for Prothena Corporation PLC.

Today’s Trading

Previous close57.91
Today’s open58.20
Day’s range57.56 - 59.02
Volume175,612
Average volume (3 months)271,129
Market cap$2.2B
Dividend yield--
Data as of 4:00pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-75.19%
Earnings growth (this year)+7.21%
Earnings growth (next 5 years)-17.08%
Revenue growth (last year)-34.35%
P/E ratioNM
Price/Sales1,601.64
Price/Book5.51

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...-0.45-1.08%
IRWDIronwood Pharmaceuti...-0.50-3.33%
FOLDAmicus Therapeutics ...-0.32-2.35%
RAREUltragenyx Pharmaceu...-1.11-2.15%
Data as of 4:00pm ET, 10/23/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$1.36
Annual revenue (last year)$1.1M
Annual profit (last year)-$160.1M
Net profit margin-15,176.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gene G. Kinney
Chief Financial Officer
Tran B. Nguyen
Corporate headquarters
Dun Laoghaire, Dublin

Forecasts